U.S., Sept. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07171528) titled 'Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer' on Aug. 19.
Brief Summary: To compare outcomes between the CRS group and the control group in patients with recurrent epithelial ovarian cancer who have undergone chemotherapy
Study Start Date: Sept. 10
Study Type: INTERVENTIONAL
Condition:
Ovarian Cancer
Intervention:
PROCEDURE: Secondary Cytoreductive Surgery
Surgery will only be performed in patients assigned to the experimental arm of the study.
The goal of secondary cytoreductive surgery is to achieve complete tumor reduction by removing all visible residual tumors (Complete cyt...